Division of Pharmacology & Toxicology, College of Pharmacy, Institute for Cellular & Molecular Biology, Institute for Neuroscience, The University of Texas at Austin, 3.510E BME, 107 W. Dean Keeton, Austin, TX 78712, USA.
Neurotoxicology. 2018 Jan;64:278-283. doi: 10.1016/j.neuro.2017.07.030. Epub 2017 Aug 5.
Over the last few years, two rare, familial diseases that lead to the onset of manganese (Mn)-induced neurotoxicity have been discovered. Loss-of-function mutations in SLC30A10, a Mn efflux transporter, or SLC39A14, a Mn influx transporter, increase Mn levels in blood and brain, and induce severe neurotoxicity. The discoveries of these genetic diseases have transformed our understanding of Mn homeostasis, detoxification, and neurotoxicity. Current knowledge about the mechanisms by which mutations in these transporters alter Mn homeostasis to induce human disease is reviewed here.
在过去的几年中,发现了两种罕见的家族性疾病,它们会导致锰(Mn)诱导的神经毒性。Mn 外排转运体 SLC30A10 或 Mn 内流转运体 SLC39A14 的功能丧失性突变会增加血液和大脑中的 Mn 水平,并引起严重的神经毒性。这些遗传性疾病的发现改变了我们对 Mn 体内平衡、解毒和神经毒性的认识。本文综述了这些转运体突变如何改变 Mn 体内平衡从而导致人类疾病的机制的现有知识。